Article
Plasma Microbial Cell-free DNA Sequencing from Over 15,000 Patients Identified a Broad Spectrum of Pathogens
2023-01-05
Abstract excerpt
<h4>ABSTRACT</h4> Microbial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic tool which enables unbiased pathogen detection from plasma. The Karius Test®, a commercial mcfDNA sequencing assay developed by and available since 2017 from Karius, Inc. (Redwood City, CA), detects and quantifies mcfDNA as molecules/μl in plasma. The commercial sample data and results for all tests conducted...
Topics
Open a Topic to create a Post that cites this publication.
- Antibiotic Resistance in Bacteria
- Bacterial Identification and Susceptibility Testing
- Blood groups and transfusion
- Cancer Genomics and Diagnostics
- COVID-19 Clinical Research Studies
- Infective Endocarditis Diagnosis and Management
- Microbial infections and disease research
- Mycobacterium research and diagnosis
Identifiers and source
- Literature Corpus work
- 94a0c6b2-896b-5399-84ca-b01bc3f29e40
- DOI
- 10.1101/2023.01.03.22283605
